IsoPlexis Corporation

08/19/2022 | Press release | Distributed by Public on 08/19/2022 19:35

Vaccines

As we wrap up National Immunization Awareness Month, this week's blog focuses on how challenges in vaccine development can be overcome with functional proteomics.

Across all vaccine types, creating long-lasting protection requires an in-depth understanding of the immune system's response to an infectious agent or its derivatives, immune monitoring to determine and predict the building of the protective response, as well as cytokine level monitoring for potential toxicities related to cytokine storms. IsoPlexis' effortlessly automated functional proteomics technology empowers vaccine developers at both the single-cell and population levels to overcome these developmental challenges.

[Link]